Figure 19.
Chemical structures of ten rhodium metalloinsertors studied in our laboratory. While all compounds were localized in the nucleus of HCT116 cells at sufficient concentrations for mismatch binding, only the compounds with low mitochondrial rhodium accumulation exhibited preferential targeting of MMR-deficient cells over MMR-proficient cells.96